Swami has previously mentioned continued communication with the FDA over the trial including extending recruitment to India. Maybe they indicated 120 patients would be sufficient at least for an interim analysis? By leaving the number at 150 they can still continue after that if they wish.
Swami has previously mentioned continued communication with the...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.64 |
Change
-0.010(0.38%) |
Mkt cap ! $1.823B | |||
| Open | High | Low | Value | Volume |
| $2.62 | $2.64 | $2.58 | $2.297M | 877.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2375 | $2.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.64 | 3584 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| PNV (ASX) Chart |